The Conference Forum announced the 13th annual PODD Drug Delivery Conference’s 2023 keynotes and plenary sessions.
NEW YORK, July 12, 2023 /PRNewswire-PRWeb/ — The Conference Forum announced the 13th annual PODD: Partnership Opportunities in Drug Delivery conference will take place October 16-17 at the Westin Copley Place, in Boston, MA.
The PODD Conference fosters collaborations between pharmaceutical, biotech, and drug delivery companies to develop more effective therapies for patients, improve the patient experience of taking medicine and extend the life cycle of the medicine.
“PODD is the most comprehensive industrial drug delivery partnering conference annually held in Boston,” said Vincent Ling, Senior Director, Center for External Innovation at Takeda. “Company representatives from medical devices, implant systems to formulation strategies are present to discuss their applications.”‘
“I love the PODD conference because it showcases some of the latest advancements in cutting-edge technologies and transformative therapies.” said Ester Caffarel-Salvador, Associate Director, Strategic Innovation, Rare Diseases at Chiesi USA. “More importantly, it offers invaluable networking opportunities with industry experts, fueling innovation in healthcare through strategic partnerships.”
The PODD 2023 keynotes and featured speakers include:
MIT’s Dr Robert Langer, a pioneer in the research and development of drug delivery technology, will discuss the state of innovation in the drug delivery industry.
Dr Al Sandrock, a leader in neurological R&D and CEO of Voyager Therapeutics is the Brain Delivery Keynote. Dr Sandrock will present on next generation AAV capsid technology as a targeted approach to gene therapy delivery to the brain.
Dr Marianne Ølholm, Senior Vice President, Devices and Delivery Solutions, Novo Nordisk, will join the PODD Conference as the Sustainability Keynote. Dr Ølholm will participate in a fireside discussion on Laying a Path for a More Sustainable Future in the Device R&D Space.
Topic areas for 2023 include: AI/ML and computational biology approaches to drug delivery, new approaches in CNS/PNS delivery, facilitating collaboration between formulation and device teams during combination product development, ophthalmic delivery, the future of digital technology in the connected device space, high-volume/high-concentration injectables and targeted delivery of gene editing technologies.
With pharmaceutical companies committing to reduce emissions and decarbonize, the PODD Conference will highlight cross-industry perspectives on integrating sustainability in the development of drug delivery technologies.
“We are thrilled to bring together KOLs and industry to understand and discuss how to improve the design and development of drug delivery systems to better meet the needs of patients,” said Andrew Goldstein, Senior Conference Producer for the PODD Conference.
Pharmaceutical companies presenting include: Sanofi, Pfizer, AstraZeneca, Amgen, Eli Lilly & Company, Novo Nordisk, Chiesi USA, Genentech, Novartis, Takeda Pharmaceuticals, Roche, Gilead Sciences, GSK, Bristol Myers Squibb, Johnson & Johnson, AbbVie, Teva Pharmaceuticals, Ionis Pharmaceuticals, Voyager Therapeutics, Apellis Pharmaceuticals and Beam Therapeutics.
To learn more about the event, visit poddconference.com
About the PODD: Partnership Opportunities in Drug Delivery Conference:
Pharma, biotech and the drug delivery industries gather annually at PODD to assess delivery needs, latest trends and information on deals and learn about a wide range of innovative drug delivery technologies that could improve the delivery of various types of drugs. This can include proteins, peptides, oligonucleotides, biologics, and small molecules and more. PODD provides business development opportunities through organized networking and a partnering tool for new, emerging and established collaborations.
About the Conference Forum:
The Conference Forum is a life science industry research firm that develops conferences, podcasts, newsletters and webinars primarily around how to get therapeutics to patients faster. They examine and challenge the complex ecosystem of drug development and delivery, bringing ideas together from a variety of sources to help advance clinical research with common goals that are patient-focused. They are committed to creating the best content, exchange of ideas and solutions among peers, as well as providing high-quality networking.
Learn more about the Conference Forum at theconferenceforum.org.
Media Contact
BreAnna Bugbee, The Conference Forum, 646-350-2580, [email protected]
SOURCE The Conference Forum
